Analyst Ratings for Idenix Pharmaceuticals Inc. (IDIX)

IDIX Rating Summary

IDIX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IDIX
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $5.75 (+5.3%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
1/6/2014 UBS Upgrade Buy
(Neutral)
11.00
(4.00)
6.27 5.46 -12.92% Details
10/16/2013 Credit Suisse Upgrade Neutral
(Underperform)
N/A
(N/A)
3.70 5.46 47.57% Details
Like IDIX Ratings? Also take a look at GILD, ACHN, VRTX, MRK

IDIX Ratings News